Followers | 228 |
Posts | 14879 |
Boards Moderated | 1 |
Alias Born | 03/29/2014 |
Saturday, August 12, 2017 2:56:32 PM
One would hope that the investigators were basing those median PFS and OS numbers off of what they were seeing in an unblinded setting. So when one looks at them through the lens of averaging those months, versus looking for the middle number, they worked out to the same month.
That could have been a coincidence, of course. And there are likely other averages that could be applied to both the treatment and control arms to arrive at that 11.3 blended number. For instance, this:
82 x 9 PFS months = 738
165 x 12.5 PFS months = 2062.50
738 + 2062.50 = 2800.5 / 248 = 11.29
Or
82 x 10 PFS months = 1100
165 x 10.3 PFS months = 1700
= 2800 = 11.29
However, you can see how the treatment and the control numbers start to draw together - the control PFS has to come up, and the treatment PFS has to come down.
And I find it quite doubtful that the control patients in this trial could eek out an average of 9 or 10 months PFS from randomization, which is 12 or 13 months PFS from diagnosis. However perhaps a bear can come along and demonstrate how that is very possible.
I know you know this... but to be clear to others... these control patients would not have received DCVax-L prior to eventing. Of course, they only receive it after an event diagnosis. So there would be no confounding - except for, of course, if some treatment patients were initially showing a false progression that was initially ruled progression.
Anyhow, how long the adjudication process took is unknown. I can't remember exactly when the company indicated they were looking at scans, etc. (I'd have to look), but they could have still been in the process by February 2017. Or not. I don't know.
Still... this is the first time I've done those numbers with PFS. I've only done averages with OS numbers. And I found it heartening that the numbers the investigators chose that would make the trial stat sig, fit like a glove to the time that the PFS events were announced.
I could have missed something, or not thought of something. I'd imagine you, ex, Avii or a few others more mathematically inclined can tell me what that is. And these numbers aren't fail safe. They don't prove the trial will be stat sig. But they help point out that it very well might be. Which as you would know, is something that has concerned me with regards to PFS. And so I was pleasantly surprised that the numbers worked out the way they did.
Recent NWBO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM